Drug-induced lung injury
نویسندگان
چکیده
منابع مشابه
Asiaticoside attenuates hyperoxia-induced lung injury in vitro andin vivo
Objective(s): Asiaticoside (AS) displays anti-inflammation, and anti-apoptosis effect, but the role of AS in hyperoxia-induced lung injury (HILI) treatment is undefined. Therefore, the aim of this study was to investigate the effects of AS on HILI on premature rats and alveolar type II (AEC II) cells.Materials and Methods: Sprague-Dawley...
متن کاملEstablishment of a rat model of radiation-induced lung injury
Background: Radiation-induced lung injury is a refractory side effect in lung cancer radiotherapy, the mechanism still remains unclear, hence an appropriate animal mode may become useful to investigate it. Materials and Methods: 50 female Wistar rats were randomly divided into 5 groups, average 10 rats/cage: A. control group B. 3Gy×10f C. 6Gy×5f D. 12.5Gy×1f E.15.3Gy×1f....
متن کاملDrug-induced oesophageal injury.
'Blackett, R L, et al, British Journal of Surgery, 1978, 65, 393. 2 Wilmore, D W, and Dudrick, S J, Archives of Surgery, 1969, 98, 256. 3 Durskin, M S, and Seigal, P D, 7ournal of the American Medical Association, 1963, 185, 966. 'Copeland, F M, et al, Surgery, Gynecology, and Obstetrics, 1974, 138, 377. 6Horshal, V L, Ause, R G, and Hoskins, P A, Archives of Surgery, 1971, 102, 353. Tanner, W ...
متن کاملDrug-induced liver injury.
Drug-induced liver injury is a frequent cause of hepatic dysfunction. Reliably establishing whether the liver disease was caused by a drug requires the exclusion of other plausible causes and the search for a clinical drug signature. The drug signature consists of the pattern of liver test abnormality, the duration of latency to symptomatic presentation, the presence or absence of immune-mediat...
متن کاملDrug-induced Liver Injury.
Drug-induced liver injury (DILI) is common and nearly all classes of medications can cause liver disease. Most cases of DILI are benign, and improve after drug withdrawal. It is important to recognize and remove the offending agent as quickly as possible to prevent the progression to chronic liver disease and/or acute liver failure. There are no definite risk factors for DILI, but pre-existing ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Klinická farmakologie a farmacie
سال: 2019
ISSN: 1212-7973,1803-5353
DOI: 10.36290/far.2018.025